Top Sell
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc. | 0 | 25 | 0 | 2 | €0.37 | - | - |
| Moleculin Biotech Inc | 3 | 25 | 0 | 3 | €0.41 | €18.42 | 4393.659% |
| Trevena Inc. | 2 | 23 | 0 | 2 | €0.15 | €6.48 | 4136.601% |
| AEterna Zentaris Inc. | 2 | 21 | 0 | 1 | €1.87 | €8.51 | 355.096% |
| Minerva Neurosciences Inc. | 0 | 11 | 0 | 2 | €2.36 | - | - |
| Organovo Holdings Inc. | 0 | 10 | 0 | 2 | €0.48 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
| Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Cyclacel Pharmaceuticals Inc. | 2 | 8 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Cara Therapeutics Inc. | 10 | 7 | 0 | 3 | €0.29 | €4.61 | 1504.590% |
| Glycomimetics Inc. | 3 | 7 | 0 | 4 | €0.14 | €9.13 | 6378.440% |
| Bluebird Bio Inc. | 7 | 6 | 3 | 0 | €0.47 | €5.47 | 1055.424% |
| Cellectar BioSciences Inc. | 4 | 4 | 0 | 0 | €1.91 | €14.75 | 672.398% |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.20 | €7.31 | 128.307% |
| Bristol-Myers Squibb | 8 | 3 | 1 | 1 | €43.94 | €65.03 | 48.004% |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.45 | €58.50 | 685.235% |
| Indivior plc | 0 | 2 | 0 | 0 | €9.60 | €6.00 | -37.500% |
| Atara Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €0.37 | - | - |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €37.02 | 8846.834% |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €6.78 | €21.44 | 216.292% |
| Coherus Bioscien. | 0 | 2 | 0 | 0 | €1.12 | - | - |
| Bayer AG ADR | 0 | 2 | 0 | 1 | €7.10 | €7.00 | -1.408% |
| Biogen Inc. | 51 | 2 | 2 | 0 | €181.10 | €283.73 | 56.668% |
| Arrowhead Pharmaceuticals Inc. | 20 | 2 | 3 | 0 | €20.06 | €54.98 | 174.083% |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €4.88 | €11.00 | 125.456% |